Evolution of the serotypes causing invasive pneumococcal disease along 2008-2022 in a Level 2 Public Hospital of the Madrid Region, in relation to their inclusion in different conjugate vaccines

The use of conjugate vaccines against Streptococcus pneumoniae originates changes in the invasive pneumococcal disease (IPD). The aim of this study was to in vestigate the evolution of S. pneumoniae serotypes isolated in the Hospital Universitario de Getafe between 2008 and 2022. 313 of S. pneumonia...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revista española de quimioterapia 2023-12, Vol.36 (6), p.597-603
Hauptverfasser:	Zaragoza Vargas, G, Cacho Calvo, J, Martínez-Arce, R, Molina Arana, D, Ramos Blázquez, B, Pérez Abeledo, M, Sanz Moreno, J C
Format:	Artikel
Sprache:	eng ; spa
Schlagworte:	Anti-Bacterial Agents - pharmacology Erythromycin - pharmacology Hospitals, Public Humans Infant Levofloxacin - pharmacology Microbial Sensitivity Tests Penicillins - pharmacology Pneumococcal Infections - epidemiology Pneumococcal Infections - prevention & control Pneumococcal Vaccines Serogroup Serotyping Streptococcus pneumoniae Vaccines, Conjugate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!